التفاصيل البيبلوغرافية
| العنوان: |
Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial |
| المؤلفون: |
Frías, Juan P *, Auerbach, Pernille, Bajaj, Harpreet S, Fukushima, Yasushi, Lingvay, Ildiko, Macura, Stanislava, Søndergaard, Anette L, Tankova, Tsvetalina I, Tentolouris, Nikolaos, Buse, John B |
| المصدر: |
In The Lancet Diabetes & Endocrinology September 2021 9(9):563-574 |
| قاعدة البيانات: |
ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder